His scientific interests lie mostly in Internal medicine, Surgery, Transplantation, Gastroenterology and Myelodysplastic syndromes. Marc Boogaerts has researched Internal medicine in several fields, including Aspergillosis and Oncology. His studies deal with areas such as Cancer, Amphotericin B and Predictive value of tests as well as Surgery.
His work deals with themes such as ST elevation, Stem cell, Myocardial infarction complications and Percutaneous coronary intervention, which intersect with Transplantation. His Gastroenterology study incorporates themes from Bone marrow failure, Incidence, Absolute neutrophil count, Immunology and Complication. In his study, Hazard ratio is inextricably linked to Retrospective cohort study, which falls within the broad field of Myelodysplastic syndromes.
Internal medicine, Immunology, Surgery, Transplantation and Gastroenterology are his primary areas of study. His research investigates the link between Internal medicine and topics such as Oncology that cross with problems in Survival rate. His Immunology study frequently draws connections between related disciplines such as Pharmacology.
His research in Surgery intersects with topics in Amphotericin B, Aspergillosis and Urology. His studies in Transplantation integrate themes in fields like Stem cell, Median follow-up, Disease and Lymphoma. His Gastroenterology research is multidisciplinary, incorporating elements of Total body irradiation, Adverse effect, Survival analysis and Mycosis.
Marc Boogaerts mainly focuses on Internal medicine, Surgery, Transplantation, Immunology and Hematopoietic stem cell transplantation. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Oncology and Cardiology. His Surgery research incorporates elements of Obstetrics and Urology.
His studies deal with areas such as Hematology, Stem cell, Median follow-up and Disease as well as Transplantation. His research in Immunology intersects with topics in Haematopoiesis, Bone marrow failure and In vivo. Marc Boogaerts has included themes like Chemotherapy, Performance status, Regimen, Retrospective cohort study and Leukemia in his Hematopoietic stem cell transplantation study.
Marc Boogaerts mostly deals with Internal medicine, Surgery, Transplantation, Myelodysplastic syndromes and Hematopoietic stem cell transplantation. His Internal medicine study incorporates themes from Stem cell, Oncology and Cardiology. His Surgery research is multidisciplinary, incorporating perspectives in Gastroenterology and Leukapheresis.
His Transplantation research is multidisciplinary, relying on both Carboplatin, Absolute neutrophil count, Granulocyte colony-stimulating factor and Urology. His Myelodysplastic syndromes research includes elements of T cell and Survival analysis. His Hematopoietic stem cell transplantation research integrates issues from Leukemia and Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome
Jan Cools;Jan Cools;Daniel J. DeAngelo;Jason Gotlib;Elizabeth H. Stover.
The New England Journal of Medicine (2003)
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
Stefan Janssens;Christophe Dubois;Jan Bogaert;Koen Theunissen.
The Lancet (2006)
Galactomannan and Computed Tomography–Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study
Johan Maertens;Koen Theunissen;Gregor Verhoef;Johnny Verschakelen.
Clinical Infectious Diseases (2005)
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients
N Schmitz;P Dreger;D.C Linch;A.H Goldstone.
The Lancet (1996)
Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy
Johan Maertens;Issam Raad;George Petrikkos;Marc Boogaerts.
Clinical Infectious Diseases (2004)
Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.
Johan Maertens;Jan Verhaegen;Katrien Lagrou;Johan Van Eldere.
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network
Martin Dreyling;Georg Lenz;Eva Hoster;Achiel Van Hoof.
Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse
Dimitri A. Breems;Wim L.J. Van Putten;Peter C. Huijgens;Gert J. Ossenkoppele.
Journal of Clinical Oncology (2005)
Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis
Johan Maertens;Jan Verhaegen;Hilde Demuynck;Penelope Brock.
Journal of Clinical Microbiology (1999)
Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.
Bob Löwenberg;Wim van Putten;Matthias Theobald;Jurg Gmür.
The New England Journal of Medicine (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: